Aytu BioScience Inc (AYTU NASDAQ) stock market data APIs
$2.3747
-0.06(-2.5%)
as of July 18, 2025
Try our APIs with
free plan!
Aytu BioScience Inc Financial Data Overview
Price chart is built with
Anychart
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above, and Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Prev. Close
2.3747
Open
2.3131
High
2.4428
Low
2.3173
52 wk Range
0.95-2.87
Market Cap
21 365 K
Shares Outstanding
8 977 K
Revenue
81 659 K
EPS
0.21
Beta
0.052
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aytu BioScience Inc data using free add-ons & libraries
Get Aytu BioScience Inc Fundamental Data
Aytu BioScience Inc Fundamental data includes:
- Net Revenue: 81 659 K
- EBITDA: 6 000 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: -0.64
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aytu BioScience Inc News
New
Aytu Boosts Liquidity with Eclipse Loan Extension
Aytu BioPharma, Inc. (NASDAQ:AYTU) is among the best growth stocks to invest in for the next 5 years. On Monday, Aytu BioPharma, Inc. (NASDAQ:AYTU) disclosed that it has successfully extended its lend...
Lake Street initiates coverage on Aytu Biosciences stock with Buy rating
Investing.com - Lake Street Capital Markets initiated coverage on Aytu Biosciences (NASDAQ:AYTU) with a Buy rating and a price target of $8.00 on Tuesday. According to InvestingPro data, the stock is ...
Aytu BioPharma to commercialise Exxua for MDD in the US
Aytu BioPharma has signed an exclusive agreement with Fabre-Kramer Pharmaceuticals to commercialise Exxua (gepirone) extended-release tablets, a new antidepressant, to the US market for major depressi...
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Emerging Growth MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4,...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
